Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 227 entries
Sorted by: Best Match Show Resources per page
Optimizing educational video through comparative trials in clinical environments

Educational trials

Aronson ID, Plass JL.
GSID: ADrChZesJjAJ
ID Aronson, JL Plass, TC Bania - Educational technology research and …, 2012 - Springer

… future uses of educational video technology that integrate and test conflicting elements of accepted theories in real-world settings. In addition to exploring relevant questions of educational theory, this paper examines how implementing comparative trials in working healthcare …

Cite
Aronson, I. D., Plass, J. L., & Bania, T. C. (2012). Optimizing educational video through comparative trials in clinical environments. Educational technology research and development, 60(3), 469-482.
Aronson, Ian David, Jan L. Plass, and Theodore C. Bania. "Optimizing educational video through comparative trials in clinical environments." Educational technology research and development 60.3 (2012): 469-482.
Copy Download .nbib Format: MLA
Nontraumatic Hemobilia in Children.

European journal of pediatric surgery reports

Bairagi A, Aronson DC.
PMID: 26171310
European J Pediatr Surg Rep. 2015 Jun;3(1):23-6. doi: 10.1055/s-0034-1372462. Epub 2014 Jul 30.

Nontraumatic hemobilia is a rare cause of upper gastrointestinal hemorrhage in children. In the developing world, infections and inflammation are the two most common causes. Two patients are presented illustrating the diagnostic difficulties. Following recognition of the site of...

Cite
Bairagi A, Aronson DC. Nontraumatic Hemobilia in Children. European J Pediatr Surg Rep. 2014;3(1):23-6doi: 10.1055/s-0034-1372462.
Bairagi, A., & Aronson, D. C. (2015). Nontraumatic Hemobilia in Children. European journal of pediatric surgery reports, 3(1), 23-6. https://doi.org/10.1055/s-0034-1372462
Bairagi, Anjana, and Aronson, Daniel C. "Nontraumatic Hemobilia in Children." European journal of pediatric surgery reports vol. 3,1 (2015): 23-6. doi: https://doi.org/10.1055/s-0034-1372462
Bairagi A, Aronson DC. Nontraumatic Hemobilia in Children. European J Pediatr Surg Rep. 2015 Jun;3(1):23-6. doi: 10.1055/s-0034-1372462. Epub 2014 Jul 30. PMID: 26171310; PMCID: PMC4487122.
Copy Download .nbib Format: NLM
Protean elephants .

BMJ (Clinical research ed.)

Aronson J.
PMID: 9651301
BMJ. 1998 Jul 04;317(7150):88B.

No abstract available.

Cite
Aronson J. Protean elephants . BMJ. 1998;317(7150):88B
Aronson, J. (1998). Protean elephants . BMJ (Clinical research ed.), 317(7150), 88B.
Aronson. "Protean elephants ." BMJ (Clinical research ed.) vol. 317,7150 (1998): 88B.
Aronson J. Protean elephants . BMJ. 1998 Jul 04;317(7150):88B. PMID: 9651301; PMCID: PMC1113482.
Copy Download .nbib Format: NLM
Circulatory assist devices 2000: an update.

Congestive heart failure (Greenwich, Conn.)

Dyke DB, Pagani FD, Aaronson KD.
PMID: 12189287
Congest Heart Fail. 2000 Sep-Oct;6(5):259-271. doi: 10.1111/j.1527-5299.2000.80165.x.

Mechanical circulatory assist devices have been used in clinical practice as a bridge to transplantation since the late 1960s. In 1982, the first totally artificial heart designated as permanent therapy was implanted, but relatively few totally artificial hearts are...

Cite
Dyke DB, Pagani FD, Aaronson KD. Circulatory assist devices 2000: an update. Congest Heart Fail. 2000;6(5):259-271doi: 10.1111/j.1527-5299.2000.80165.x.
Dyke, D. B., Pagani, F. D., & Aaronson, K. D. (2000). Circulatory assist devices 2000: an update. Congestive heart failure (Greenwich, Conn.), 6(5), 259-271. https://doi.org/10.1111/j.1527-5299.2000.80165.x
Dyke, D BS, et al. "Circulatory assist devices 2000: an update." Congestive heart failure (Greenwich, Conn.) vol. 6,5 (2000): 259-271. doi: https://doi.org/10.1111/j.1527-5299.2000.80165.x
Dyke DB, Pagani FD, Aaronson KD. Circulatory assist devices 2000: an update. Congest Heart Fail. 2000 Sep-Oct;6(5):259-271. doi: 10.1111/j.1527-5299.2000.80165.x. PMID: 12189287.
Copy Download .nbib Format: NLM
Anecdotes that provide definitive evidence.

BMJ (Clinical research ed.)

Aronson JK, Hauben M.
PMID: 17170419
BMJ. 2006 Dec 16;333(7581):1267-9. doi: 10.1136/bmj.39036.666389.94.

No abstract available.

Cite
Aronson JK, Hauben M. Anecdotes that provide definitive evidence. BMJ. 2006;333(7581):1267-9doi: 10.1136/bmj.39036.666389.94.
Aronson, J. K., & Hauben, M. (2006). Anecdotes that provide definitive evidence. BMJ (Clinical research ed.), 333(7581), 1267-9. https://doi.org/10.1136/bmj.39036.666389.94
Aronson, Jeffrey K, and Hauben, Manfred. "Anecdotes that provide definitive evidence." BMJ (Clinical research ed.) vol. 333,7581 (2006): 1267-9. doi: https://doi.org/10.1136/bmj.39036.666389.94
Aronson JK, Hauben M. Anecdotes that provide definitive evidence. BMJ. 2006 Dec 16;333(7581):1267-9. doi: 10.1136/bmj.39036.666389.94. PMID: 17170419; PMCID: PMC1702478.
Copy Download .nbib Format: NLM
Variation in the composition of gallstones simultaneously formed in the gallbladder.

The American journal of pathology

Phemister DB, Aronson HG.
PMID: 19970584
Am J Pathol. 1941 Sep;17(5):673-680.11.

No abstract available.

Cite
Phemister DB, Aronson HG. Variation in the composition of gallstones simultaneously formed in the gallbladder. Am J Pathol. 1941;17(5):673-680.11
Phemister, D. B., & Aronson, H. G. (1941). Variation in the composition of gallstones simultaneously formed in the gallbladder. The American journal of pathology, 17(5), 673-680.11.
Phemister, D B, and Aronson, H G. "Variation in the composition of gallstones simultaneously formed in the gallbladder." The American journal of pathology vol. 17,5 (1941): 673-680.11.
Phemister DB, Aronson HG. Variation in the composition of gallstones simultaneously formed in the gallbladder. Am J Pathol. 1941 Sep;17(5):673-680.11. PMID: 19970584; PMCID: PMC1965253.
Copy Download .nbib Format: NLM
Factors related to use of prostate cancer screening: the Alberta Tomorrow Project.

Open medicine : a peer-reviewed, independent, open-access journal

Richardson H, Aronson KJ, James A, McGregor ES, Bryant H.
PMID: 20101288
Open Med. 2007 Apr 14;1(1):e3-e12.

BACKGROUND: Very few data are available on the determinants of PSA testing in Canada, and it is a matter of debate whether prostate-specific antigen (PSA) screening in asymptomatic men age 50 and older with no risk factors for prostate...

Cite
Richardson H, Aronson KJ, James A, et al. Factors related to use of prostate cancer screening: the Alberta Tomorrow Project. Open Med. 2007;1(1):e3-e12
Richardson, H., Aronson, K. J., James, A., McGregor, E. S., & Bryant, H. (2007). Factors related to use of prostate cancer screening: the Alberta Tomorrow Project. Open medicine : a peer-reviewed, independent, open-access journal, 1(1), e3-e12.
Richardson, Harriet, et al. "Factors related to use of prostate cancer screening: the Alberta Tomorrow Project." Open medicine : a peer-reviewed, independent, open-access journal vol. 1,1 (2007): e3-e12.
Richardson H, Aronson KJ, James A, McGregor ES, Bryant H. Factors related to use of prostate cancer screening: the Alberta Tomorrow Project. Open Med. 2007 Apr 14;1(1):e3-e12. PMID: 20101288; PMCID: PMC2801912.
Copy Download .nbib Format: NLM
Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.

Frontiers in oncology

Ashbury JE, Lévesque LE, Beck PA, Aronson KJ.
PMID: 23227451
Front Oncol. 2012 Dec 05;2:177. doi: 10.3389/fonc.2012.00177. eCollection 2012.

Selective serotonin reuptake inhibitors (SSRIs) are a widely prescribed class of antidepressants. Laboratory and epidemiologic evidence suggests that a prolactin-mediated mechanism secondary to increased serotonin levels at neuronal synapses could lead to a potentially carcinogenic effect of SSRIs. In...

Cite
Ashbury JE, Lévesque LE, Beck PA, et al. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer. Front Oncol. 2012;2:177doi: 10.3389/fonc.2012.00177.
Ashbury, J. E., Lévesque, L. E., Beck, P. A., & Aronson, K. J. (2012). Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer. Frontiers in oncology, 2177. https://doi.org/10.3389/fonc.2012.00177
Ashbury, Janet E, et al. "Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer." Frontiers in oncology vol. 2 (2012): 177. doi: https://doi.org/10.3389/fonc.2012.00177
Ashbury JE, Lévesque LE, Beck PA, Aronson KJ. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer. Front Oncol. 2012 Dec 05;2:177. doi: 10.3389/fonc.2012.00177. eCollection 2012. PMID: 23227451; PMCID: PMC3514533.
Copy Download .nbib Format: NLM
Introducing the EBM Verdict: research evidence relevant to clinical practice.

BMJ evidence-based medicine

Heneghan C, Brassey J, Aronson J, O'Sullivan JW.
PMID: 30700435
BMJ Evid Based Med. 2019 Jun;24(3):85-86. doi: 10.1136/bmjebm-2019-111172. Epub 2019 Jan 30.

No abstract available.

Cite
Heneghan C, Brassey J, Aronson J, et al. Introducing the EBM Verdict: research evidence relevant to clinical practice. BMJ Evid Based Med. 2019;24(3):85-86doi: 10.1136/bmjebm-2019-111172.
Heneghan, C., Brassey, J., Aronson, J., & O'Sullivan, J. W. (2019). Introducing the EBM Verdict: research evidence relevant to clinical practice. BMJ evidence-based medicine, 24(3), 85-86. https://doi.org/10.1136/bmjebm-2019-111172
Heneghan, Carl, et al. "Introducing the EBM Verdict: research evidence relevant to clinical practice." BMJ evidence-based medicine vol. 24,3 (2019): 85-86. doi: https://doi.org/10.1136/bmjebm-2019-111172
Heneghan C, Brassey J, Aronson J, O'Sullivan JW. Introducing the EBM Verdict: research evidence relevant to clinical practice. BMJ Evid Based Med. 2019 Jun;24(3):85-86. doi: 10.1136/bmjebm-2019-111172. Epub 2019 Jan 30. PMID: 30700435.
Copy Download .nbib Format: NLM
Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature.

BMC medicine

Onakpoya IJ, Heneghan CJ, Aronson JK.
PMID: 30823879
BMC Med. 2019 Mar 02;17(1):56. doi: 10.1186/s12916-019-1294-9.

The original article [1] contains a minor error whereby the dates for year of first launch and year of first report of adverse reaction for iophendylate in e-Appendix Table 1 are mistakenly presented as 1946 and 1975 respectively.

Cite
Onakpoya IJ, Heneghan CJ, Aronson JK. Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2019;17(1):56doi: 10.1186/s12916-019-1294-9.
Onakpoya, I. J., Heneghan, C. J., & Aronson, J. K. (2019). Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC medicine, 17(1), 56. https://doi.org/10.1186/s12916-019-1294-9
Onakpoya, Igho J, et al. "Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature." BMC medicine vol. 17,1 (2019): 56. doi: https://doi.org/10.1186/s12916-019-1294-9
Onakpoya IJ, Heneghan CJ, Aronson JK. Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2019 Mar 02;17(1):56. doi: 10.1186/s12916-019-1294-9. PMID: 30823879; PMCID: PMC6397477.
Copy Download .nbib Format: NLM
Right-sided heart failure: diagnosis and treatment strategies.

Current treatment options in cardiovascular medicine

Matthews JC, Dardas TF, Dorsch MP, Aaronson KD.
PMID: 18647588
Curr Treat Options Cardiovasc Med. 2008 Aug;10(4):329-41. doi: 10.1007/s11936-008-0053-6.

Right ventricular (RV) dysfunction in the setting of cardiomyopathy, ischemia, and pulmonary hypertension is associated with high morbidity and mortality, but therapeutic clinical trials examining RV failure as a primary outcome are lacking. This review focuses on the ontologic,...

Cite
Matthews JC, Dardas TF, Dorsch MP, et al. Right-sided heart failure: diagnosis and treatment strategies. Curr Treat Options Cardiovasc Med. 2008;10(4):329-41doi: 10.1007/s11936-008-0053-6.
Matthews, J. C., Dardas, T. F., Dorsch, M. P., & Aaronson, K. D. (2008). Right-sided heart failure: diagnosis and treatment strategies. Current treatment options in cardiovascular medicine, 10(4), 329-41. https://doi.org/10.1007/s11936-008-0053-6
Matthews, Jennifer Cowger, et al. "Right-sided heart failure: diagnosis and treatment strategies." Current treatment options in cardiovascular medicine vol. 10,4 (2008): 329-41. doi: https://doi.org/10.1007/s11936-008-0053-6
Matthews JC, Dardas TF, Dorsch MP, Aaronson KD. Right-sided heart failure: diagnosis and treatment strategies. Curr Treat Options Cardiovasc Med. 2008 Aug;10(4):329-41. doi: 10.1007/s11936-008-0053-6. PMID: 18647588.
Copy Download .nbib Format: NLM
Lifetime caffeine intake and the risk of epithelial ovarian cancer.

Cancer epidemiology

Grundy A, Sandhu S, Arseneau J, Gilbert L, Gotlieb WH, Aronson KJ, Koushik A.
PMID: 34800867
Cancer Epidemiol. 2021 Nov 17;76:102058. doi: 10.1016/j.canep.2021.102058. Epub 2021 Nov 17.

BACKGROUND: Caffeine intake has been inconsistently associated with the risk of ovarian cancer in previous studies. The measure of caffeine in these studies has not always distinguished between caffeinated and decaffeinated sources, and the time for which intake was...

Cite
Grundy A, Sandhu S, Arseneau J, et al. Lifetime caffeine intake and the risk of epithelial ovarian cancer. Cancer Epidemiol. 2021;76:102058doi: 10.1016/j.canep.2021.102058.
Grundy, A., Sandhu, S., Arseneau, J., Gilbert, L., Gotlieb, W. H., Aronson, K. J., & Koushik, A. (2021). Lifetime caffeine intake and the risk of epithelial ovarian cancer. Cancer epidemiology, 76102058. https://doi.org/10.1016/j.canep.2021.102058
Grundy, Anne, et al. "Lifetime caffeine intake and the risk of epithelial ovarian cancer." Cancer epidemiology vol. 76 (2021): 102058. doi: https://doi.org/10.1016/j.canep.2021.102058
Grundy A, Sandhu S, Arseneau J, Gilbert L, Gotlieb WH, Aronson KJ, Koushik A. Lifetime caffeine intake and the risk of epithelial ovarian cancer. Cancer Epidemiol. 2021 Nov 17;76:102058. doi: 10.1016/j.canep.2021.102058. Epub 2021 Nov 17. PMID: 34800867.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 227 entries